Clinical trials
Completed Phase 2 Carcinoma, Merkel Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Memorial Sloan Kettering Cancer Center | 2 |
| 4SC AG | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Incyte Corporation | 1 |
| OncoSec Medical Incorporated | 1 |
| Prof. Dr. med. Dirk Schadendorf | 1 |
| SWOG Cancer Research Network | 1 |
| Trans Tasman Radiation Oncology Group | 1 |
| University Hospital, Grenoble | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Merkel Cell | 14 |
| Carcinoma, Neuroendocrine | 1 |
| Melanoma | 1 |
| Neoplasms, Unknown Primary | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.